Press-release for stocks publishing date 2021 - 08

Prices are updated after-hours

VYNE Therapeutics Announces Approval of AMZEEQ® (Minocycline) and ZILXI® (Minocycline) in Chinese Economic Pilot Zone
Published: 2021-08-02 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.35 4.44% 3.43% 28K

| -13.6% | O: 1.1% H: 4.0% C: 0.0%
chinese approval

73%

27%

MTTR | News M | $4.8 175.86% 63.6% 71M

AGBA | $2.5 100.0% 56.6% 200M

MLEC | $2.47 76.43% 42.62% 78M

NUWE | $0.334 29.96% 40.99% 2.5M

EDBL | News | $6.26 66.49% 40.13% 16M

ATGL | $2.86 46.25% 32.8% 180K

ONFO | $0.6088 38.68% 27.74% 7.3M

VIVK | $1.43 33.65% 27.7% 530K

MNTS | $0.5 35.69% 26.3% 4.7M

SDIG A | $3.64 35.32% 26.0% 990K

Save your searches and get alerts when important news are released.